Skip to main content
European Commission logo
français français
CORDIS - Résultats de la recherche de l’UE
CORDIS
CORDIS Web 30th anniversary CORDIS Web 30th anniversary

ERA-Net Cofund in Personalised Medicine

Objectif

ERA PerMed will serve as a funding vehicle of topics identified in the Strategic Research and Innovation Agenda (SRIA) in Personalised Medicine and the Action Plan of ICPerMed.

ERA PerMed will coordinate R&I efforts of the participating partners (funding agencies from EU, associate countries to H2020 and third countries). The main objective is planning, implementing, monitoring and disseminate up to four joint transnational calls (JTCs) tackling the value change in full to fund multidisciplinary transnational research projects covering each at least three slots of the value chain regarding Personalised Medicine.

The ERA PerMed consortium is open to enlargement for the planned JTCs. According to funding scheme’s rules, ERA PerMed partners commit themselves to implement one call with top-up co-funding from the EC, and include funded project monitoring. Additionally, up to three non-cofunded calls will be carried, in order to broaden the scope of action of the efforts made by the EC and funding organizations to foster the Personalised Medicine Research Community and to be able to take into account recent changes within the landscape of personalised medicine, e.g. new developments of emerging technologies and societal challenges, which reinforces and amplifies the expected impact of ERA PerMed funding activity.

Cooperation and links with ICPerMed and a dialogue with patient organisations, other European stakeholders and initiatives are crucial for both R&I and the implementation of their results and sustainability, which reinforces and amplifies the expected impact of ERA PerMed funding activity.

Appel à propositions

H2020-SC1-2016-2017

Voir d’autres projets de cet appel

Sous appel

H2020-SC1-2017-Single-Stage-RTD

Régime de financement

ERA-NET-Cofund - ERA-NET Cofund

Coordinateur

INSTITUTO DE SALUD CARLOS III
Contribution nette de l'UE
€ 196 775,00
Adresse
MONFORTE DE LEMOS 5
28029 Madrid
Espagne

Voir sur la carte

Région
Comunidad de Madrid Comunidad de Madrid Madrid
Type d’activité
Research Organisations
Liens
Coût total
€ 717 500,00

Participants (33)